For instance, p38 MAPK, TGF-β, BMP, the DREAM complex, Wnt/β-catenin signaling, and various histone modifiers have been implicated in maintaining and reactivating QCCs under different cancer conditions [8,13,25,27,29,37,42,43]. The gene discussed is KCNIP3; the disease is cancer.